ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma.
Jci Insight
Seidel, Philipp P; Rubarth, Anne A; Zodel, Kyra K; Peighambari, Asin A; Neumann, Felix F; Federkiel, Yannick Y; Huang, Hsin H; Hoefflin, Rouven R; Adlesic, Mojca M; Witt, Christian C; Hoffmann, David J DJ; Metzger, Patrick P; Lindemann, Ralph K RK; Zenke, Frank T FT; Schell, Christoph C; Boerries, Melanie M; von Elverfeldt, Dominik D; Reichardt, Wilfried W; Follo, Marie M; Albers, Joachim J; Frew, Ian J IJ
Thomson, Jason J; Bewicke-Copley, Findlay F; Anene, Chinedu Anthony CA; Gulati, Abha A; Nagano, Ai A; Purdie, Karin K; Inman, Gareth J GJ; Proby, Charlotte M CM; Leigh, Irene M IM; Harwood, Catherine A CA; Wang, Jun J